BT Workeneh

Nephrologist/MD Anderson Cancer Center/Dialysis Medical Director/Founding Member of ASON/TX Gulf Coast Lupus Society Board Member

[BT Workeneh @bdubNephro]

@ShrutiGkidney speaking about mitigation of chemotherapy and immunotherapy induced nephrotoxicity at Bayou City Bean Club. @MDAndersonNews @onconephsociety

[Fitsum Asnakech Tilahun - ፍፁም @fitse_t]

Some facts about Dialysis situation in Ethiopia
From Dr.Wubshet Jote presentation today on Advancing Kidney Care in Ethiopia

Around ~2500 patient on dialysis in Ethiopia
No peritoneal dialysis
No national Registry for patients on dialysis
Cost per dialysis ~$25-35 @YetenaW

[BT Workeneh @bdubNephro]

@winkeldoc speaking at Bayou City Bean Club about Afib and anticoagulation in CKD and ESKD. What is best approach and options to consider for our patients? @MDAndersonNews @bcmhouston @NephBCM

[BT Workeneh @bdubNephro]

@JamieLinMD at Bayou City Bean Club talking to us about her work in early ICI-nephritis detection. @onconephsociety @MDAndersonNews

[BT Workeneh @bdubNephro]

Dr. Totini Chatterjee nephrologist and geriatrician @utmbhealth discussing CKD Management in Older Adults at Bayou City Bean Club. @MDAndersonNews

[Sandra Herrmann MD, FASN @HerrmannMd]

Dr @bdubNephro presenting: Developing Onconephrology Program
@MayoClinicNeph
@onconephsociety
@MDAndersonNews
@LeticiaRolonMD

[Sandra Herrmann MD, FASN @HerrmannMd]

Paraneoplastic Phenomena Session at Onconephrology Symposium moderated by Dr @bdubNephro and Dr @andreaangioi
Starting with Cryoglobulinemia by Professor Roccatello
@MayoClinicNeph
@onconephsociety

[BT Workeneh @bdubNephro]

@onconeph Dr. Kitchlu discussing the implications of mis-estimating GFR at #Onconephrology particularly, drug eligibility, dosing, dose adjustment, and trial inclusion in cancer patients. @onconephsociety

[BT Workeneh @bdubNephro]

Dr. Ala Abudayyeh at the ASON Onconephrology Symposium at Mayo Clinic expertly discussing ICI renal toxicity @MDAndersonNews @onconephsociety

[BT Workeneh @bdubNephro]

@JayaKala11 speaking at Bayou City Bean Club about Cancer patients impacted by kidney injury and failure. @MDAndersonNews

[BT Workeneh @bdubNephro]

Dr. Juan Cintron-Garcia @MDAndersonNews graduate of Onconeohrology Fellow and future faculty @rushumedcollege giving excellent talk about Cell therapies at Bayou City Bean Club

[Mayo Clinic Nephrology @MayoClinicNeph]

Mayo Clinic is pleased to announce a two-day course on Sept 11-12, the Onco-Nephrology Symposium 2025, introduces the latest updates & advances in the field of onco nephrology. Please join us for this exciting event! To learn more, click here https://t.co/l3hl3IcztD

[Sreedhar Mandayam @Srmanday]

Thank you Senator Cruz for meeting with us to hear the needs of the Lupus Community
@LupusOrg @SenTedCruz

[BT Workeneh @bdubNephro]

Autism awareness workshop happening today. For more information about valuable knowledge sharing visit https://t.co/5k09jpUbhk

[BT Workeneh @bdubNephro]

@VelezNephHepato speaking at Bayou Ciry Bean Club giving update in the diagnosis and management of HRS. Interesting FeNa <0.44 may be more sensitive in this population 🤔

[BT Workeneh @bdubNephro]

A Commentary on Protein intake and mortality in older adults with CKD https://t.co/SkgRykCViz

[BCM Department of Medicine @BCMDeptMedicine]

🏆 Congratulations to Dr. Sankar Navaneethan on receiving the prestigious Garabed Eknoyan Award from the @nkf! 🎉 He will be honored at the 2025 Spring Clinical Meetings for his outstanding impact to advancing kidney disease research and care.

[BT Workeneh @bdubNephro]

Dr. Hania Kassem @NephBCM speaking about home dialysis at NKF Symposium in Houston, more patients eligible for peritoneal dialysis than we might think. #NKF #Texas

[BT Workeneh @bdubNephro]

Dr. Hania Kassem from @NephBCM speaking at Bayou City Bean Club about how climate change is impacting CKD and dialysis care, and how dialysis is affecting the environment.

[Vineet Gupta 🧬🧫 @gupta__vineet]

Huge thank you to our local #Nephrology-Guru @farhaddanesh123 and @MDAndersonNews #Nephrology team for the invite to present our research and our new #ClinicalTrials in #LupusNephritis. Such an engaging and thoughtful audience. Learned tons 🙏
We are super excited about targeting #myeloid cells via #integrin-agonists as first-in-class novel LN therapeutics. So great to get feedback from this amazing group.
@utmbhealth
@UTMBinnovations